FDA approves ravulizumab for treatment of paroxysmal nocturnal hemoglobinuriaDecember 21, 2018HematologyRare Diseases
Survivors of childhood Hodgkin lymphoma face 14-fold risk of second cancersDecember 20, 2018PediatricsOncologyHematology
Telemedicine not widely usedDecember 14, 2018CardiologyOncologyPulmonologyHematologyBusiness of MedicineHospice & Palliative MedicineImmunology
Parental leave for residentsDecember 13, 2018Men's HealthWomen's HealthHematologyPulmonologyRare DiseasesInfectious DiseasesBusiness of Medicine
